EU Provides Horizon Discovery $1.7M to Develop Cancer Models | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today announced it has received a €1.2 million ($1.7 million) grant from the EU's Seventh Framework Programme and joined the Colon Cancer and Therapeutics, or COLTHERES, Consortium.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.